The integration profile of EIAV-based vectors

被引:38
|
作者
Hacker, Caroline V.
Vink, Conrad A.
Wardell, Theresa W.
Lee, Sheena
Treasure, Peter
Kingsman, Susan M.
Mitrophanous, Kyriacos A.
Miskin, James E.
机构
[1] Oxford BioMedica UK Ltd, Medawar Ctr, Oxford OX4 4GA, England
[2] Peter Treasure Stat Serv Ltd, Kings Lynn PE34 3NR, England
关键词
lentiviral vectors; EIAV; gene therapy; integration; safety;
D O I
10.1016/j.ymthe.2006.06.006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lentiviral vectors based on equine infectious anemia virus (EIAV) stably integrate into dividing and nondividing cells such as neurons, conferring long-term expression of their transgene. The integration profile of an EIAV vector was analyzed in dividing HEK293T cells, alongside an HIV-1 vector as a control, and compared to a random dataset generated in silico. A multivariate regression model was generated and the influence of the following parameters on integration site selection determined: (a) within/not within a gene, (b) GC content within 20 kb, (c) within 10 kb of a CpG island, (d) gene density within a 2-Mb window, and (e) chromosome number. The majority of the EIAV integration sites (68%; n = 458) and HIV-1 integration sites (72%; n = 162) were within a gene, and both vectors favored AT-rich regions. Sites within genes were examined using a second model to determine the influence of the gene-specific parameters, gene region, and transcriptional activity. Both EIAV and HIV-1 vectors preferentially integrated within active genes. Unlike the gammaretrovirus MLV, EIAV and HIV-1 vectors do not integrate preferentially into the promoter region or the 5' end of the transcription unit.
引用
收藏
页码:536 / 545
页数:10
相关论文
共 50 条
  • [41] Assessment of integration-defective HIV and EIAV vector in vitro and in vivo
    Ellis, Scott
    Fong-Wong, Liang
    Iqball, Sharifah
    Thoree, Vinay
    Mitrophanous, Kyri
    Binley, Katie
    HUMAN GENE THERAPY, 2008, 19 (10) : 1194 - 1195
  • [42] Integration of retroviral vectors
    Gabriel, Richard
    Schmidt, Manfred
    von Kalle, Christof
    CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (05) : 592 - 597
  • [43] Novel rAAV vectors for episomal and integration based gene transfer
    Kay, Mark A.
    HUMAN GENE THERAPY, 2014, 25 (11) : A16 - A16
  • [44] Development of an RCL assay for EIAV based products
    Miskin, JE
    Roehl, H
    Westfall, D
    Rohll, J
    Chipchase, D
    Jolly, D
    Kingsman, SM
    Mitrophanous, KA
    MOLECULAR THERAPY, 2004, 9 : S33 - S33
  • [45] Profile vectors in the lattice of subspaces
    Gerbner, Daniel
    Patkos, Balazs
    DISCRETE MATHEMATICS, 2009, 309 (09) : 2861 - 2869
  • [46] NEW RAAV VECTORS AND APPROACHES FOR EPISOMAL AND INTEGRATION BASED GENE TRANSFER
    Kay, Mark A.
    JOURNAL OF GENE MEDICINE, 2015, 17 (8-9): : 179 - 179
  • [47] IMPROVE - Identifying Minimal PROfile VEctors for similarity based access control
    Misra, Gaurav
    Such, Jose M.
    Balogun, Hamed
    2016 IEEE TRUSTCOM/BIGDATASE/ISPA, 2016, : 868 - 875
  • [48] Deletion of the LTR Enhancer/Promoter Has No Impact on the Integration Profile of MLV Vectors in Human Hematopoietic Progenitors
    Moiani, Arianna
    Miccio, Annarita
    Rizzi, Ermanno
    Severgnini, Marco
    Pellin, Danilo
    Suerth, Julia Debora
    Baum, Christopher
    De Bellis, Gianluca
    Mavilio, Fulvio
    PLOS ONE, 2013, 8 (01):
  • [49] Profile-based object matching for information integration
    Doan, A
    Lu, Y
    Lee, Y
    Han, JW
    IEEE INTELLIGENT SYSTEMS, 2003, 18 (05) : 54 - 59
  • [50] Artificial IN-peptide fusions provide BET-independent MLV-vectors with a safer integration profile
    Van Looveren, D.
    El Ashkar, S.
    Schenk, F.
    Vranckx, L. S.
    De Rijck, J.
    Debyser, Z.
    Modlich, U.
    Gijsbers, R.
    HUMAN GENE THERAPY, 2016, 27 (11) : A182 - A182